The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy

被引：0
|
作者：
Xiangjiao Meng
Zhaoqin Huang
Renben Wang
Yuhong Jiao
Huijuan Li
Xiaoqing Xu
Rui Feng
Kunli Zhu
Shumei Jiang
Hongjiang Yan
Jinming Yu
机构：
[1] Department of Radiation Oncology of Shandong Cancer Hospital and Institute,Department of Radiology
[2] Provincial Hospital Affiliated to Shandong University,undefined
[3] Department of Medicine of Shandong Cancer Hospital and Institute,undefined
来源：
Radiation Oncology | / 9卷
关键词：
Rectal cancer; EZH2; Neoadjuvant chemoradiotherapy; Tumor response; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Meng, Xiangjiao
    Huang, Zhaoqin
    Wang, Renben
    Jiao, Yuhong
    Li, Huijuan
    Xu, Xiaoqing
    Feng, Rui
    Zhu, Kunli
    Jiang, Shumei
    Yan, Hongjiang
    Yu, Jinming
    RADIATION ONCOLOGY, 2014, 9
  • [2] Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
    Byoung Yong Shim
    Der Sheng Sun
    Hye Sung Won
    Myung Ah Lee
    Soon Uk Hong
    Ji-Han Jung
    Hyeon-Min Cho
    Yoon Ho Ko
    BMC Cancer, 16
  • [3] The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Dou, Xue
    Wang, Renben
    Meng, Xiangjiao
    Yan, Hongjiang
    Jiang, Shumei
    Zhu, Kunli
    Xu, Xiaoqing
    Chen, Dong
    Song, Xianrang
    Mu, Dianbin
    CANCER BIOMARKERS, 2015, 15 (02) : 181 - 188
  • [4] Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
    Shim, Byoung Yong
    Sun, Der Sheng
    Won, Hye Sung
    Lee, Myung Ah
    Hong, Soon Uk
    Jung, Ji-Han
    Cho, Hyeon-Min
    Ko, Yoon Ho
    BMC CANCER, 2016, 16
  • [5] Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
    Zhang, Yiyi
    Xu, Meifang
    Chen, Jianhua
    Chen, Kui
    Zhuang, Jinfu
    Yang, Yuanfeng
    Liu, Xing
    Guan, Guoxian
    ONCOTARGETS AND THERAPY, 2020, 13 : 9185 - 9201
  • [6] Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
    Arikan, Rukiye
    Alkis, Hilal
    Isik, Selver
    Yasar, Alper
    celebi, Abdussamet
    Majidova, Nargiz
    Adli, Mustafa
    Sever, Nadiya
    Demircan, Nazim C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [7] Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy
    Moreno Garcia, V.
    Cejas, P.
    Blanco Codesido, M.
    Feliu Batlle, J.
    de Castro Carpeno, J.
    Belda-Iniesta, C.
    Barriuso, J.
    Sanchez, J. J.
    Larrauri, J.
    Gonzalez-Baron, M.
    Casado, E.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (07) : 741 - 748
  • [8] Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Arrazubi, V.
    Suarez, J.
    Guerrero, D.
    Gomez, M.
    Viudez, A.
    Arias, F.
    Balen, E.
    Vera, R.
    COLORECTAL DISEASE, 2013, 15 (04) : 428 - 435
  • [9] Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer
    Huh, Jung Wook
    Yun, Seong Hyeon
    Kim, Seok Hyung
    Park, Yoon Ah
    Cho, Yong Beom
    Kim, Hee Cheol
    Lee, Woo Yong
    Park, Hee Chul
    Choi, Doo Ho
    Park, Joon Oh
    Park, Young Suk
    Chun, Ho-Kyung
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (10) : 1772 - 1778
  • [10] Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
    Nishi, Masaaki
    Yamashita, Shoko
    Takasu, Chie
    Wada, Yuma
    Yoshikawa, Kozo
    Tokunaga, Takuya
    Nakao, Toshihiro
    Kashihara, Hideya
    Yoshimoto, Toshiaki
    Shimada, Mitsuo
    BMC CANCER, 2025, 25 (01) : 99
12345